Cargando…
Prognostic value of delta-like protein 3 combined with thyroid transcription factor-1 in small-cell lung cancer
Rovalpituzumab tesirine is a promising delta-like protein 3 (DLL3)-targeted antibody-drug conjugate for the treatment of small-cell lung cancer (SCLC). Thyroid transcription factor-1 (TTF-1) and DLL3 protein are associated with SCLC, and may be used to identify patients, who respond to the DLL3-targ...
Autores principales: | Yan, Li-Xu, Liu, Yan-Hui, Li, Zhi, Luo, Dong-Lan, Li, Yu-Fa, Yan, Jing-Hai, Zhang, Jia-Tao, Liu, Chao, Liu, Xun-Hua, He, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676644/ https://www.ncbi.nlm.nih.gov/pubmed/31452726 http://dx.doi.org/10.3892/ol.2019.10538 |
Ejemplares similares
-
Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis
por: Chen, Benchao, et al.
Publicado: (2020) -
Differential distribution and prognostic value of CD4(+) T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes
por: Shi, Zhi-Yong, et al.
Publicado: (2022) -
SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012) -
Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer
por: Gong, Mou-chun, et al.
Publicado: (2021) -
Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
por: Xu, Haiyan, et al.
Publicado: (2022)